Enanta Pharmaceuticals (ENTA) PT Raised to $77 at JMP Securities
Tweet
Share
E-mailGet Alerts ENTA Hot Sheet
Price: $13.52 -2.1%
Rating Summary:
15 Buy, 3 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 17 | Down: 23 | New: 12
Rating Summary:
15 Buy, 3 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 17 | Down: 23 | New: 12
Join SI Premium – FREE
JMP Securities analyst Roy Buchanan raised the price target on Enanta Pharmaceuticals (NASDAQ: ENTA) to $77.00 (from $73.00) while maintaining a Market Outperform rating.
You May Also Be Interested In
- Bicara Therapeutics Inc (BCAX) PT Raised to $39 at BTIG
- Morgan Stanley Upgrades LG Electronics (066570:KS) to Overweight
- Trex (TREX) PT Raised to $49 at Stifel
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
